-
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Average Rating of "Moderate Buy" by Analysts
Source: Buzz FX / 15 Jan 2025 02:56:16 America/New_York
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Average Rating of "Moderate Buy" by Analysts Written by MarketBeat January 15, 2025 Share Link copied to clipboard. Amicus Therapeutics, Inc. ( NASDAQ:FOLD - Get Free Report ) has been assigned
Read more...